Analyst consensus for a range of metrics is provided below. The consensus represents up to 15 analyst forecasts for each metric and was compiled on 27 July 2021.
|Analyst consensus1||HY 2021||FY 2021|
|Fee based revenue (£m)||743||1,495|
|Adjusted operating expenses (£m)||(597)||(1,188)|
|Adjusted operating profit (£m)||146||307|
|Adjusted profit before tax (£m)||154||322|
|Adjusted capital generation (£m)||157||283|
|Adjusted diluted earnings per share (p)||5.9||12.3|
|Dividend per share2 (p)||6.9||14.6|
|Net flows (£bn)||(2.1)||(3.6)|
|Assets under management and administration3 (£bn)||545||550|
1 Analyst consensus based on research published between 9 March 2021 and 27 July 2021
2 As set out in the Annual report and accounts 2020, it is the Board’s current intention to maintain the total dividend at 14.6p (with the interim and final at the same amount per share), until it is covered at least 1.5 times by adjusted capital generation, at which point the Board will seek to grow the dividend in line with its assessment of the underlying medium term growth in profitability
3 Certain analyst estimates for AUMA within this consensus do not fully reflect recent corporate actions, in particular the completion of the sale of Parmenion in June 2021
The forecasts used to produce this consensus have been provided to abrdn plc by a number of registered investment analysts and are, as such, publicly available information. abrdn plc has not verified, accepts no liability or responsibility for and expresses no opinion in respect of, the accuracy of the information or forecasts, or the basis thereof it, nor has it commented on the accuracy of any forecasts, individually or collectively, and it does not intend to do so in the future. abrdn plc assumes no obligation or responsibility to update or revise the information contained in the consensus to reflect circumstances existing after the date this consensus is published. Forecasts are by definition forward-looking and are therefore subject to risks and uncertainties that may materially affect eventual results.
|Bank of America Merrill Lynch|
|Deutsche Bank AG London|
|Exane BNP Paribas|
|JP Morgan Cazenove|
|Keefe, Bruyette & Woods Ltd|
|Royal Bank of Canada|
Copyright © abrdn plc 2021. All rights reserved.
abrdn plc is registered in Scotland (SC286832) at 1 George Street, Edinburgh, EH2 2LL